Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 495

1.

Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM).

Wong YW, Fonarow GC, Mi X, Peacock WF 4th, Mills RM, Curtis LH, Qualls LG, Hernandez AF.

Am Heart J. 2013 Aug;166(2):349-56. doi: 10.1016/j.ahj.2013.05.014. Epub 2013 Jul 1.

PMID:
23895819
2.

Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM.

J Am Coll Cardiol. 2008 Aug 12;52(7):534-40. doi: 10.1016/j.jacc.2008.05.010.

4.

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Scientific Advisory Committee and Investigators.; ADHERE Study Group..

J Am Coll Cardiol. 2005 Jul 5;46(1):57-64.

5.

Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.

Aziz EF, Kukin M, Javed F, Pratap B, Sabharwal MS, Tormey D, Frankenberger O, Herzog E.

Hosp Pract (1995). 2011 Feb;39(1):126-32. doi: 10.3810/hp.2011.02.382.

PMID:
21441767
6.

Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.

Kociol RD, Hammill BG, Hernandez AF, Klaskala W, Mills RM, Curtis LH, Fonarow GC.

Clin Cardiol. 2011 Nov;34(11):682-8. doi: 10.1002/clc.20986. Epub 2011 Nov 6.

7.

The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.

Scrutinio D, Ammirati E, Guida P, Passantino A, Raimondo R, Guida V, Sarzi Braga S, Canova P, Mastropasqua F, Frigerio M, Lagioia R, Oliva F.

J Heart Lung Transplant. 2014 Apr;33(4):404-11. doi: 10.1016/j.healun.2013.12.005. Epub 2013 Dec 16.

PMID:
24485712
8.

Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.

Gardetto NJ, Greaney K, Arai L, Brenner A, Carroll KC, Howerton NM, Lee M, Pada L, Tseng M, Maisel AS.

Crit Pathw Cardiol. 2008 Sep;7(3):153-72. doi: 10.1097/HPC.0b013e31818207e4.

PMID:
18791404
9.

Early vasoactive drugs improve heart failure outcomes.

Peacock WF, Emerman C, Costanzo MR, Diercks DB, Lopatin M, Fonarow GC.

Congest Heart Fail. 2009 Nov-Dec;15(6):256-64. doi: 10.1111/j.1751-7133.2009.00112.x.

10.
11.

Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis.

Tallman TA, Peacock WF, Emerman CL, Lopatin M, Blicker JZ, Weber J, Yancy CW; ADHERE Registry..

Acad Emerg Med. 2008 Apr;15(4):355-62. doi: 10.1111/j.1553-2712.2008.00059.x.

12.
13.

Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days.

Kociol RD, Liang L, Hernandez AF, Curtis LH, Heidenreich PA, Yancy CW, Fonarow GC, Peterson ED.

Am Heart J. 2013 Jun;165(6):987-994.e1. doi: 10.1016/j.ahj.2013.02.006. Epub 2013 Apr 6.

PMID:
23708171
14.

Short- and long-term rehospitalization and mortality for heart failure in 4 racial/ethnic populations.

Vivo RP, Krim SR, Liang L, Neely M, Hernandez AF, Eapen ZJ, Peterson ED, Bhatt DL, Heidenreich PA, Yancy CW, Fonarow GC.

J Am Heart Assoc. 2014 Oct 16;3(5):e001134. doi: 10.1161/JAHA.114.001134.

15.

Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction.

Eapen ZJ, Greiner MA, Fonarow GC, Yuan Z, Mills RM, Hernandez AF, Curtis LH.

Am Heart J. 2014 Mar;167(3):369-375.e2. doi: 10.1016/j.ahj.2013.12.001. Epub 2013 Dec 11.

PMID:
24576522
16.

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.

Am Heart J. 2008 Oct;156(4):662-73. doi: 10.1016/j.ahj.2008.04.030.

PMID:
18926148
17.

Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.

Peacock WF 4th, Fonarow GC, Emerman CL, Mills RM, Wynne J; ADHERE Scientific Advisory Committee and Investigators.; Adhere Study Group..

Cardiology. 2007;107(1):44-51. Epub 2006 May 4.

PMID:
16741357
18.

Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.

Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.

Pharmacotherapy. 2006 Aug;26(8):1078-85.

19.

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP; ADHERE Scientific Advisory Committee and Investigators..

Am Heart J. 2005 Feb;149(2):209-16.

PMID:
15846257
20.

Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.

Echols MR, Felker GM, Thomas KL, Pieper KS, Garg J, Cuffe MS, Gheorghiade M, Califf RM, O'Connor CM.

J Card Fail. 2006 Dec;12(9):684-8.

PMID:
17174228

Supplemental Content

Support Center